IAVI and Biofabri/Zendal Announce First Vaccinations in the IMAGINE Clinical Trial, a Large-scale Safety and Efficacy Trial of the Tuberculosis Vaccine Candidate MTBVAC

Tuberculosis (TB) is the world's deadliest infectious disease, killing 1.25 million people in 2023.MTBVAC is a…

Continue Reading

First Participants Vaccinated with IAVI’s Ebola Sudan Vaccine Candidate in Uganda Amid Ebola Outbreak

The vaccine candidate is being evaluated in a ring vaccination trial as part of a comprehensive…

Continue Reading

IAVI and IPD Sign Agreement Formalizing Collaboration to Advance Vaccine Development, Manufacturing, and Access in Africa

Agreement signed to establish collaboration between IAVI and IPDNew partnership aims to accelerate vaccine development and…

Continue Reading

Ubiquity Launches Digital CX Operations Center in Ghana

Bespoke global outsourcing firm proudly enters African market; company to create hundreds of new jobs ACCRA,…

Continue Reading

SPACES: Digital Innovation Meets Contemporary Art at Phillips

A Selling Exhibition of Multidisciplinary Works by 8 Global ArtistsLONDON, ENGLAND / ACCESSWIRE / September 25,…

Continue Reading

Africa CDC and IAVI Sign Memorandum of Understanding to Enhance Vaccine and Antibody Research Capacity in Africa

NEW YORK, NY / ACCESSWIRE / September 25, 2024 / The Africa Centres for Disease Control…

Continue Reading